Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.

Saved in:
Bibliographic Details
Title: Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Authors: Koole S; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Stein R; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Sikorska K; Department of Biostatistics, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands., Barton D; Department of Gynaecological Oncology, Royal Marsden Hospital NHS Trust, London, UK., Perrin L; Queensland Centre for Gynaecological Cancer, Herston, Queensland, Australia., Brennan D; Gynaecology Oncology, Mater Misericordiae University Hospital, Dublin, Ireland., Zivanovic O; Department of Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Mosgaard BJ; Department of Gynaecology, Copenhagen University Hospital, Copenhagen, Denmark., Fagotti A; Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Colombo PE; Department of Surgical Oncology, Institut régional du Cancer de Montpellier, Montpellier, France., Sonke G; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Driel WJV; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands w.v.driel@nki.nl.; Center for Gynaecologic Oncology Amsterdam, Center for Gynaecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Dutch Gynecological Oncology Group (DGOG), the Netherlands, the Netherlands.; Dutch Peritoneal Oncology Group (DPOG), the Netherlands, the Netherlands.
Corporate Authors: OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group
Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2020 Jun; Vol. 30 (6), pp. 888-892. Date of Electronic Publication: 2020 Mar 23.
Publication Type: Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32205449
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Koole+S%22">Koole S</searchLink>; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Stein+R%22">van Stein R</searchLink>; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sikorska+K%22">Sikorska K</searchLink>; Department of Biostatistics, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Barton+D%22">Barton D</searchLink>; Department of Gynaecological Oncology, Royal Marsden Hospital NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Perrin+L%22">Perrin L</searchLink>; Queensland Centre for Gynaecological Cancer, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Brennan+D%22">Brennan D</searchLink>; Gynaecology Oncology, Mater Misericordiae University Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Zivanovic+O%22">Zivanovic O</searchLink>; Department of Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Mosgaard+BJ%22">Mosgaard BJ</searchLink>; Department of Gynaecology, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Fagotti+A%22">Fagotti A</searchLink>; Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Colombo+PE%22">Colombo PE</searchLink>; Department of Surgical Oncology, Institut régional du Cancer de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Sonke+G%22">Sonke G</searchLink>; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Driel+WJV%22">Driel WJV</searchLink>; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands w.v.driel@nki.nl.; Center for Gynaecologic Oncology Amsterdam, Center for Gynaecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Dutch Gynecological Oncology Group (DGOG), the Netherlands, the Netherlands.; Dutch Peritoneal Oncology Group (DPOG), the Netherlands, the Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22OVHIPEC-2+Steering+Committee+and+the+Dutch+OVHIPEC+group%22">OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229111626%22">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</searchLink> [Int J Gynecol Cancer] 2020 Jun; Vol. 30 (6), pp. 888-892. <i>Date of Electronic Publication: </i>2020 Mar 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9111626 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1525-1438 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221048891X%22">1048891X </searchLink><i>NLM ISO Abbreviation: </i>Int J Gynecol Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32205449
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/ijgc-2020-001231
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 888
    Titles:
      – TitleFull: Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koole S
      – PersonEntity:
          Name:
            NameFull: van Stein R
      – PersonEntity:
          Name:
            NameFull: Sikorska K
      – PersonEntity:
          Name:
            NameFull: Barton D
      – PersonEntity:
          Name:
            NameFull: Perrin L
      – PersonEntity:
          Name:
            NameFull: Brennan D
      – PersonEntity:
          Name:
            NameFull: Zivanovic O
      – PersonEntity:
          Name:
            NameFull: Mosgaard BJ
      – PersonEntity:
          Name:
            NameFull: Fagotti A
      – PersonEntity:
          Name:
            NameFull: Colombo PE
      – PersonEntity:
          Name:
            NameFull: Sonke G
      – PersonEntity:
          Name:
            NameFull: Driel WJV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2020 Jun
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1525-1438
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
              Type: main
ResultId 1